MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in MAIA Biotechnology, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +8 vs. Q3 2023
- Shares held
- 803.3K
- +485.0K (+152.4%) vs. Q3 2023
- Total value
- $957.8K
- +$258.1K (+36.9%) vs. Q3 2023
- New holders
- 9
- 9 more added
- Sold out
- 1
- 1 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MAIA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $19.4M |
| Q1 2026 | 33 | $18.4M |
| Q4 2025 | 26 | $4.09M |
| Q3 2025 | 19 | $3.49M |
| Q2 2025 | 20 | $3.95M |
| Q1 2025 | 20 | $2.26M |
| Q4 2024 | 20 | $2.75M |
| Q3 2024 | 17 | $4.15M |
| Q2 2024 | 21 | $6.09M |
| Q1 2024 | 20 | $1.50M |
| Q4 2023 | 22 | $957.8K |
| Q3 2023 | 14 | $699.6K |
| Q2 2023 | 12 | $709.1K |
| Q1 2023 | 6 | $246.7K |
| Q4 2022 | 6 | $1.04M |
| Q3 2022 | 9 | $763.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding MAIA Biotechnology, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 174,159 | $203.8K | 0.00% | +80,659+86.3% | Added |
| Sabby Management, LLC | 130,510 | $152.7K | 1.35% | +130,510 | New |
| Renaissance Technologies LLC | 111,200 | $130.0K | 0.00% | +111,200 | New |
| Centric Wealth Management | 67,198 | $96.8K | 0.03% | +2,542+3.9% | Added |
| Bridgeway Capital Management, LLC | 75,700 | $88.6K | 0.00% | +24,100+46.7% | Added |
| Citadel Advisors LLC | 57,473 | $67.2K | 0.00% | +57,473 | New |
| Geode Capital Management, LLC | 44,557 | $52.2K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 23,965 | $28.0K | 0.01% | +23,965 | New |
| Naviter Wealth, LLC | 22,168 | $25.9K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 21,300 | $24.9K | 0.00% | +21,300 | New |
| Northern Trust Corp | 20,273 | $23.7K | 0.00% | +20,273 | New |
| BlackRock Inc. | 17,209 | $20.1K | 0.00% | +3,237+23.2% | Added |
| Wealth Enhancement Advisory Services, LLC | 14,800 | $17.3K | 0.00% | +14,800 | New |
| Brookstone Capital Management | 12,658 | $14.8K | 0.00% | +12,658 | New |
| Morgan Stanley | 5,095 | $5.96K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,594 | $4.21K | 0.00% | −1,329−27.0% | Reduced |
| UBS Group AG | 998 | $1.17K | 0.00% | +865+650.4% | Added |
| Sunbelt Securities, Inc. | 150 | $176 | 0.00% | +100+200.0% | Added |
| JPMorgan Chase & Co | 78 | $91 | 0.00% | +67+609.1% | Added |
| Wells Fargo & Company | 69 | $81 | 0.00% | +6+9.5% | Added |
| Bank of America Corp | 8 | $9 | 0.00% | +8 | New |
| Royal Bank of Canada | 148 | $0 | 0.00% | +121+448.1% | Added |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −17,550−100.0% | Sold out |